Health & Wellness, Resources

FDA announced the approval of a new drug specifically formulated to treat postpartum depression (PPD)

The FDA announced the approval of a new drug, Zulresso, that is specifically formulated to treat postpartum depression (PPD). It is administered via IV infusion over 60 hours and requires hospital admission. While there has been some negativity surrounding the…

Continue reading